Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. Press Releases
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
CommuniquÚs de presse de la sociÚtÚ NOVO NORDISK A/S
06/14NOVO NORDISK A/Sá : Share repurchase programme (Form 6-K)
PU
06/07NOVO NORDISK A/Sá : Share repurchase programme (Form 6-K)
PU
06/07NOVO NORDISK A/Sá : – Share repurchase programme
AQ
06/07NOVO NORDISK A/Sá : Wegovy™ (semaglutide 2.4 mg), the first and only once-..
PU
06/04NOVO NORDISK A/Sá : FDA approves obesity drug that helped people cut weight 15%
AQ
06/04NOVO NORDISK A/Sá : Wegovy™ (semaglutide 2.4 mg), the first and only once-..
AQ
06/01NOVO NORDISK A/Sá : Share repurchase programme (Form 6-K)
PU
06/01NOVO NORDISK A/Sá : resubmits once-weekly semaglutide 2.0 mg for the treatment o..
PU
05/28NOVO NORDISK A/Sá : resubmits once-weekly semaglutide 2.0 mg for the treatment o..
AQ
05/25NOVO NORDISK A/Sá : – Share repurchase programme
AQ
05/18AETERNA ZENTARISá : Announces the Start of Preclinical Development of Macimoreli..
AQ
05/18NOVO NORDISK A/Sá : Share repurchase programme (Form 6-K)
PU
05/13HEMOPHILIA A PIPELINE : Emerging Therapies and Key pharma players involved by De..
AQ
05/12NOVO NORDISK A/Sá : Share repurchase programme (Form 6-K)
PU
05/12NOVO NORDISK A/Sá : purchases B shares worth DKK 2,586 million from Novo Holding..
PU
05/07NOVO NORDISK A/Sá : Trading in Novo Nordisk shares by board members, executives ..
AQ
05/07NOVO NORDISK A/Sá : – Share repurchase programme
AQ
05/07NOVO NORDISK A/Sá : purchases B shares worth DKK 2,586 million from Novo Holding..
AQ
05/05NOVO NORDISK : Q1 Earnings Snapshot
AQ
05/05NOVO NORDISK A/Sá : Indicate by check mark whether the registrant files or will ..
PU
05/05NOVO NORDISK A/Sá : net profit increased by 6% in the first three months of 2021
AQ
05/04NOVO NORDISK A/Sá : Share repurchase programme
PU
04/28NOVO NORDISK A/Sá : - Reduction of the share capital
AQ
04/27NOVO NORDISK A/Sá : - Articles of Association
AQ
04/27NOVO NORDISK A/Sá : – Reduction of the share capital
AQ
04/26NOVO NORDISK A/Sá : – Share repurchase programme
AQ
04/21NOVO NORDISK A/Sá : to initiate phase 3a development in obesity with oral semagl..
AQ
04/21ADULT GROWTH HORMONE DEFICIENCY PIPE : Emerging Therapies and Key pharma players..
AQ
04/15DIABETES PIPELINE : Emerging Therapies and Key pharma players involved by DelveI..
AQ
04/12NOVO NORDISK A/Sá : – Share repurchase programme
AQ
04/06ZUR ROSEá : Introducing DocMorris Adipositas Care (Obesity Care), a digital hub ..
AQ
04/06DOCMORRIS : Introducing DocMorris Adipositas Care (Obesity Care), a digital hub ..
AQ
04/06ZUR ROSEá : Introducing DocMorris Adipositas Care (Obesity Care), a digital hub ..
AQ
04/05ZUR ROSEá : Novo Nordisk and Zur Rose Group - Introducing DocMorris Adipositas C..
AQ
04/01ZUR ROSEá : Introducing DocMorris Adipositas Care (Obesity Care), a digital hub ..
AQ
03/29NOVO NORDISK A/Sá : - Saxenda recommended for approval by European Medicines Age..
AQ
03/26NOVO NORDISK A/Sá : Resolutions from the Annual General Meeting of Novo Nordisk ..
AQ
03/25CORRECTION : Resolutions from the Annual General Meeting of Novo Nordisk A/S
AQ
03/25NOVO NORDISK A/Sá : - Articles of Association
AQ
03/23NOVO NORDISK A/Sá : Xellia Pharmaceuticals appoints Preben Haaning to its Board ..
AQ
03/22NOVO NORDISK A/Sá : receives Refusal to File letter for once-weekly semaglutide ..
AQ
03/22NOVO NORDISK A/Sá : – Share repurchase programme
AQ
03/19GILEAD SCIENCESá : and Novo Nordisk expand NASH clinical collaboration
AQ
03/08Automated Insulin Delivery Systems Market Size Worth $ 7.81 Billion By 2027 a..
AQ
03/08DIABETES AND OBESITY : treatment and trials update
AQ
03/08NOVO NORDISK A/Sá : – Share repurchase programme
AQ
03/05DANCANN PHARMA A/Sá : appoints Malene Gottfredsen as Product Manager
AQ
02/26NOVO NORDISK A/Sá : invests DKK 500 million in expanding tablet production facil..
AQ
02/25NOVO NORDISK A/Sá : and the University of Toronto announce joint 200 DKK million..
AQ
02/23NOVO NORDISK A/Sá : Notice for the Annual General Meeting of Novo Nordisk A/S
AQ
02/22NOVO NORDISK A/Sá : Aeterna Zentaris Announces Closing of $29.7 Million Bought D..
AQ
02/22NOVO NORDISK A/Sá : – Share repurchase programme
AQ
02/16NOVO NORDISK A/Sá : Trading in Novo Nordisk shares by board members, executives ..
AQ
02/12NOVO NORDISK A/Sá : Trading in Novo Nordisk shares by board members, executives ..
AQ
02/12NOVO NORDISK A/Sá : Two Exclusive Interviews Released with Pfizer and Novo Nordi..
AQ
02/11NOVO NORDISK A/Sá : Kimball to run 2 Indianapolis races with Foyt's team
AQ
02/10NOVO NORDISK A/Sá : Trading in Novo Nordisk shares by board members, executives ..
AQ
02/08NOVO NORDISK A/Sá : – Share repurchase programme
AQ
02/05NOVO NORDISK A/Sá : Trading in Novo Nordisk shares by board members, executives ..
AQ
02/05NOVO NORDISK A/Sá : files annual report with the SEC
AQ
02/03NOVO NORDISK A/Sá : Annual Report (SEC Filing - 20-F)
PU
02/03NOVO NORDISK : 4Q Earnings Snapshot
AQ
02/03NOVO NORDISK A/Sá : net profit increased by 8% in 2020
AQ
02/01NOVO NORDISK A/Sá : receives positive opinion from the European regulatory autho..
AQ
01/25NOVO NORDISK A/Sá : – Share repurchase programme
AQ
01/20NOVO NORDISK A/Sá : files for regulatory approval in the US of once-weekly semag..
AQ
01/11NOVO NORDISK A/Sá : – Share repurchase programme
AQ
01/06DICERNA PHARMACEUTICALSá : Announces Novo Nordisk's Nomination of First Candidat..
AQ
2020NOVO NORDISK A/Sá : files for EU regulatory approval of once-weekly semaglutide ..
AQ
2020NOVO NORDISK A/Sá : – Share repurchase programme
AQ
2020NOVO NORDISK A/Sá : files for EU regulatory approval of once-weekly semaglutide ..
AQ
2020NOVO NORDISK A/Sá : files for EU regulatory approval of once-weekly semaglutide ..
AQ
2020NOVO NORDISK A/Sá : to enter phase 3 development in Alzheimer's disease with ora..
AQ
2020NOVO NORDISK A/Sá : Presentation ()
PU
2020NOVO NORDISK A/Sá : to enter phase 3 development in Alzheimer's disease with ora..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on NOVO NORDISK A/S
08/05/21